Favresse et al. retrospectively reported on 38 citrated plasmas samples, including eight patients with TTP, observing no misclassification (<10% ADAMTS13 activity cut-off) [20]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.